Xenon(XENE) - 2025 Q3 - Quarterly Results

Xenon Reports Third Quarter 2025 Financial Results & Business Update VANCOUVER, BC and BOSTON, MA, November 3, 2025 – Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today reported financial results for the third quarter ended September 30, 2025 and provided a business update. "We are entering an important, catalyst-rich period for Xenon. We ...